Cargando…

SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease

Multiple studies have demonstrated a critical role of Sirtuin-1 (SIRT1) deacetylase in protecting kidney cells from cellular stresses. A protective role of SIRT1 has been reported in both podocytes and renal tubular cells in multiple kidney disease settings, including diabetic kidney disease (DKD)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Yifei, Lee, Kyung, He, John Cijiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199382/ https://www.ncbi.nlm.nih.gov/pubmed/30386303 http://dx.doi.org/10.3389/fendo.2018.00624

Ejemplares similares

The Role of SIRT1 in Diabetic Kidney Disease
por: Yacoub, Rabi, et al.
Publicado: (2014)

Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
por: Yan, Jiayi, et al.
Publicado: (2022)

SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
por: Qi, Wenxiu, et al.
Publicado: (2022)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease
por: Nugent, Melinda M., et al.
Publicado: (2015)

Relationship between Macrophages and Tissue Microenvironments in Diabetic Kidneys
por: Yan, Jiayi, et al.
Publicado: (2023)

Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
por: Yang, Ming, et al.
Publicado: (2022)

COVID-19 Acute Kidney Injury: Current Knowledge and Barriers of Research
por: Zhong, Yifei, et al.
Publicado: (2021)

Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease
por: Shaffner, James, et al.
Publicado: (2021)

Role of Transcription Factor Acetylation in Diabetic Kidney Disease
por: Liu, Ruijie, et al.
Publicado: (2014)

Puerarin attenuates diabetic kidney injury through interaction with Guanidine nucleotide‐binding protein Gi subunit alpha‐1 (Gnai1) subunit
por: Zhu, Qingqing, et al.
Publicado: (2022)

Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism
por: Liu, Tongtong, et al.
Publicado: (2023)

SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication
por: Meng, Teng, et al.
Publicado: (2020)

Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2017)

Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2018)

Publisher Correction: Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes
por: Li, Xueling, et al.
Publicado: (2017)

A Novel Mechanism of Regulation for Exosome Secretion in the Diabetic Kidney
por: Feng, Ye, et al.
Publicado: (2021)

Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases
por: Zhong, Yifei, et al.
Publicado: (2013)

Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease
por: Li, Haiyang, et al.
Publicado: (2022)

FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function
por: Alqudah, Abdelrahim, et al.
Publicado: (2021)

Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease
por: Zhong, Yifei, et al.
Publicado: (2011)

SIRT6’s function in controlling the metabolism of lipids and glucose in diabetic nephropathy
por: Wang, Ying, et al.
Publicado: (2023)

REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease
por: Wang, Xinyu, et al.
Publicado: (2022)

Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease
por: Mishra, Deendayal Das, et al.
Publicado: (2023)

Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
por: Wang, Yu, et al.
Publicado: (2023)

SIRT1 in Secretory Organ Cancer
por: Frazzi, Raffaele
Publicado: (2018)

Editorial: Cell Cross-talk in Diabetic Kidney Diseases
por: Hong, Quan, et al.
Publicado: (2022)

SIRT1 and Autophagy: Implications in Endocrine Disorders
por: Kim, Ji Yong, et al.
Publicado: (2022)

Sleep Duration and Diabetic Kidney Disease
por: Tan, Nicholas Y. Q., et al.
Publicado: (2019)

Sirtuin Family and Diabetic Kidney Disease
por: Bian, Che, et al.
Publicado: (2022)

Epigenetic modification in diabetic kidney disease
por: Liu, Zhe, et al.
Publicado: (2023)

Editorial: SIRT Family in Endocrinology
por: Li, Tian, et al.
Publicado: (2019)

The Role of SIRT3 in the Osteoporosis
por: Hu, Siwang, et al.
Publicado: (2022)

Metformin, an Anti-diabetic Drug to Target Leukemia
por: Biondani, Giulia, et al.
Publicado: (2018)

Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression
por: Fan, Ying, et al.
Publicado: (2019)

Weighted Gene Co-Expression Network Analysis Identifies ANGPTL4 as a Key Regulator in Diabetic Cardiomyopathy via FAK/SIRT3/ROS Pathway in Cardiomyocyte
por: Dai, Lei, et al.
Publicado: (2021)

Stratification of diabetic kidney diseases via data-independent acquisition proteomics–based analysis of human kidney tissue specimens
por: Huang, Qinghua, et al.
Publicado: (2022)

Contribution of mitochondrial gene variants in diabetes and diabetic kidney disease
por: Li, Meng, et al.
Publicado: (2022)

Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus
por: Zhang, Xinxin, et al.
Publicado: (2022)

Effects of sleep duration and changes in body mass index on diabetic kidney disease: a prospective cohort study
por: Liu, Cong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pptd7sctcten1dgtge12jt4qjq